Feature Articles

ASH Clinical News takes a deeper look at hot topics in medicine.

  • Affordable Care Act: Exit, Stage Right Thursday, February 2nd, 2017 | February 2017, Volume 3, Issue 3

    The rollback of the Affordable Care Act (ACA) is underway. Within hours of taking the oath of office on January 20, President Donald Trump signed an executive order that undermines enforcement of Former President Barack Obama’s signature legislation. Just a week earlier, the GOP-led Senate and House voted to start the process of repealing the […]

  • Cartwheels for CAR T-Cell Therapy? Tuesday, January 17th, 2017 | January Annual Meeting Edition 2017, Volume 3, Issue 2

    Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach to targeted immunotherapy to treat cancer, and the details can seem like the stuff of science fiction: A patient’s T cells are harvested, re-engineered to become targeted “cancer killers,” and infused back into the patient’s body to proliferate and eradicate cancer cells. In some cases, […]

  • Predatory Publishing: The Dark Side of the Open-Access Movement Thursday, December 29th, 2016 | January 2017, Volume 3, Issue 1

    In October 2016, we dived deep into the open-access (OA) movement – a publishing model in which a scientific article is made freely available – examining the benefits and the drawbacks of this approach to research (“Public Access: The Pros and Cons of Open-Access Publishing”). This month, we take a closer look at another, darker […]

  • Supporting Palliative Care Tuesday, November 22nd, 2016 | December 2016, Volume 2, Issue 12

    While early research supports the benefits of integrating palliative care into hematology, more is needed to successfully marry the two specialties. Any discussion of palliative care and the subspecialty of palliative medicine should always begin with a clear definition of what, exactly, palliative care and its goals are, according to Thomas LeBlanc, MD, a medical […]

  • Who’s In and Who’s Out? Tuesday, November 22nd, 2016 | December 2016, Volume 2, Issue 12

    Finding the balance in clinical trial eligibility between too strict, not strict enough, and “just right” To assess a drug or device’s safety and efficacy, researchers and regulators often rely on randomized, controlled clinical trials. And, to ensure that those trials provide reproducible, valuable results with minimal risk to the trial participants, investigators designing the […]

1 of 8
back to top